Surtex Expansys II Skin Graft Mesher

Transcription

Surtex Expansys II Skin Graft Mesher
Surtex Expansys® II
Skin Graft Expansion System
Unique design eliminates need to change the cutter during operation.
Easy adjustment for thin and thick skin grafts.
Graft Plates in two expansion ratios.
Surtex Expansys® II
Skin Graft Expansion System
Single cutter cuts skin graft into geometrical shaped mesh & enlarges skin surface.
Graft expansion predetermined by graft carrying plates, eliminating need to
change cutter during operation.
Continuous feed design prevents graft carrying plate from
being loaded incorrectly and allow multiple plates to be
used without interruption.
Graft thickness adjustment feature allow expansion on thin
and thick grafts.
Easy availability of replacement parts.
Availability
Surtex Expansys® II
Surtex Expansys® II Complete
with Sterilization Case
Carrier Plates
SG-200-00
Graft Carrier Plate Factor
1.5:1 (Box of 20)
SG-210-15
SG-200-90
Graft Carrier Plate Factor
3:1 (Box of 20)
SG-210-30
®
Surtex Expansys II
Instrument Only
All rights reserved. Technical alterations are possible. This leaflet maybe
used for no other purpose than offering, buying and selling of our products.
No part may be copied or reproduced in any form. In the case of misuse we
retain the rights to recall our catalogues and price lists and take legal actions.
© 2011. SURTEX INSTRUMENT LTD. ALL RIGHTS RESERVED.
PRINTED IN THE UK.
47 Kingston Hill
London, KT2 7PS
United Kingdom
Phone: +44 (208) 123 3513
http://www.surtex-instruments.co.uk

Similar documents

Graft Versus Host Disease GvHD Treatment Market Revenue, Opportunity, Forecast and Value Chain 2016-2026

Graft Versus Host Disease GvHD Treatment Market Revenue, Opportunity, Forecast and Value Chain 2016-2026 Graft versus Host disease occurs after a stem cell or bone marrow transplant. High dose treatment destroy cancer cells along with that it simultaneously destroys healthy cells. Stem cell and bone marrow transplant treatments are used in reconstructing damaged cells, surrounding cancer tumors. Normally after high dose treatment, patient receives bone marrow from a donor through drip which resumes production of blood cells. Graft versus Host Disease occurs when certain types of white blood cells. This is caused due to the transplanted cells (graft) see recipient’s body (host) as exotic, thus transplanted cells attack the host body.

More information